Group | At risk (n) | Category of myopic maculopathy | Staphyloma (%) | |||||
C0 (%) | C1 (%) | C2 (%) | C3 (%) | C4 (%) | Plus lesions (%) | |||
Age | ||||||||
50–59 | 1580 | 1564 (99.0) | 5 (0.3) | 3 (0.2) | 0 (0.0) | 1 (0.1) | 7 (0.4) | 3 (0.2) |
60–69 | 1536 | 1497 (97.5) | 22 (1.4) | 9 (0.6) | 2 (0.1) | 0 (0.0) | 6 (0.4) | 4 (0.3) |
70+ | 1353 | 1207 (89.2) | 112 (8.28) | 31 (2.3) | 1 (0.1) | 0 (0.0) | 2 (0.1) | 1 (0.1) |
Total | 4469 | 4268 (95.5) | 139 (3.11) | 43 (1.0) | 3 (0.1) | 1 (0.1) | 15 (0.3) | 8 (0.2) |
Gender | ||||||||
Male | 2239 | 2138 (95.5) | 74 (3.3) | 23 (1.0) | 1 (0.1) | 1 (0.1) | 2 (0.1) | 7 (0.3) |
Female | 2230 | 2130 (95.5) | 65 (2.9) | 20 (0.9) | 2 (0.1) | 0 (0.0) | 13 (0.6) | 1 (0.1) |
Total | 4469 | 4268 (95.5) | 139 (2.7) | 43 (1.0) | 3 (0.1) | 1 (0.1) | 15 (0.3) | 8 (0.2) |
C0, normal; C1, tessellated fundus; C2, diffuse chorioretinal atrophy; C3, patchy chorioretinal atrophy; C4, macular atrophy.